Peptide Purification Methods Compared 2026: RP-HPLC, IEX, HIC, SEC, and Multimodal Approaches

Technical Comparison | 2026-07-09 | 10 min read

A 2026 technical comparison of peptide purification methods: RP-HPLC, ion exchange chromatography, hydrophobic interaction chromatography, size exclusion chromatography, and when to use each for achieving ≥95-99% purity.

Why purification method matters

A peptide's biological activity depends on having the correct sequence, the correct modifications, and minimal contamination from related sequences. The purification method determines which contaminants are removed and which persist. Two peptides with identical HPLC purity percentages can have different biological activity if their impurity profiles are different.

Understanding purification methods helps buyers:

• Specify the right purity requirements
• Interpret COA data correctly
• Evaluate whether a supplier's purification approach is appropriate for their compound
• Request specific analytical tests when needed

Reversed-phase HPLC (RP-HPLC): the workhorse

RP-HPLC separates peptides based on hydrophobicity. A hydrophobic stationary phase (C18, C8, or C4) retains hydrophobic peptides longer than hydrophilic peptides. A gradient of organic solvent (acetonitrile or methanol) elutes peptides in order of increasing hydrophobicity.

Advantages:

• Highest resolution for most peptide separations
• Excellent reproducibility with modern HPLC systems
• Compatible with UV, MS, and ELSD detection
• Scalable from analytical (4.6mm) to prep scale (50mm+)
• Directly compatible with mass spectrometry

Limitations:

• Poor separation of charge variants (they have similar hydrophobicity)
• Poor separation of some structural isomers
• Requires organic solvents (acetonitrile)
• Aggregated peptides may co-elute with monomer under some conditions

Typical RP-HPLC conditions for GLP-1 peptides:

| Parameter | Typical value | | --- | --- | | Column | C18, 5μm, 250 × 4.6mm (analytical) | | Mobile phase A | 0.1% TFA in water | | Mobile phase B | 0.1% TFA in acetonitrile | | Gradient | 5-95% B over 30-60 minutes | | Detection | 220nm (peptide bond) | | Temperature | 40-60°C (reduces tailing) | | Flow rate | 1 mL/min (analytical) |

High-pH RP-HPLC uses ammonium bicarbonate buffer (pH 8-9) instead of TFA. It provides different selectivity than acidic conditions and is useful for separating peptides that co-elute under standard conditions. Increasingly used as a second-dimension purification for GLP-1 analogs.

Ion exchange chromatography (IEX): charge-based separation

IEX separates peptides based on net charge. Cation exchange resin (negative surface charge) retains positively charged peptides; anion exchange resin (positive surface charge) retains negatively charged peptides.

When to use IEX:

• Peptides with significant charge heterogeneity (deamidation, oxidation products)
• Peptides that aggregate and are hard to separate by RP-HPLC
• As a capture step before RP-HPLC (removes salts and polar impurities)
• For GLP-1 peptides with charge variants from degradation

Advantages:

• High capacity for charge-based separation
• Works under physiological salt conditions
• Can handle crude peptide mixtures with high salt
• Complementary to RP-HPLC

Limitations:

• Lower resolution than RP-HPLC for most sequences
• Requires pH optimization for each peptide
• Buffers may interfere with downstream analytical methods
• Less scalable than RP-HPLC

IEX for GLP-1 peptides: GLP-1 analogs with deamidation products (Asn → Asp) gain one negative charge. Cation exchange can separate the deamidated product from the intact peptide because the deamidated form has lower net positive charge at the operating pH.

Hydrophobic interaction chromatography (HIC): hydrophobicity without organic solvents

HIC separates peptides based on hydrophobicity using a hydrophilic stationary phase (phenyl or butyl) with a high-salt mobile phase. Unlike RP-HPLC, HIC does not require organic solvents — peptides elute by decreasing salt concentration.

When to use HIC:

• Separating aggregated peptides from monomer (aggregates are more hydrophobic)
• Separating fatty acid-conjugated peptides (the fatty acid adds hydrophobicity)
• When organic solvents are undesirable for downstream processing
• As a second-dimension purification after IEX

Advantages:

• No organic solvents required
• Gentle conditions preserve biological activity
• Excellent for aggregated peptides
• Scalable to manufacturing scale

Limitations:

• Lower resolution than RP-HPLC
• Requires high salt concentrations for binding
• Salt removal step needed before final formulation

HIC for fatty acid-conjugated peptides (GLP-1 analogs): The C18 fatty diacid chain on tirzepatide, semaglutide, and other GLP-1 analogs adds significant hydrophobicity. HIC can separate correctly conjugated from incorrectly conjugated or unconjugated material — a separation that RP-HPLC may not resolve.

Size exclusion chromatography (SEC): separating by size

SEC separates peptides based on hydrodynamic radius. Larger species (aggregates, oligomers) elute first; smaller species (monomer, fragments) elute later. SEC is primarily used for aggregate analysis, not primary purification.

When to use SEC:

• Aggregate quantification in stability studies
• Separating monomer from dimer or higher oligomer
• Desalting and buffer exchange
• Final polishing step after RP-HPLC

Advantages:

• Gentle conditions (aqueous, ambient temperature)
• No binding interactions that could damage the peptide
• Excellent for aggregate analysis
• Direct compatibility with downstream biological assays

Limitations:

• Low resolution — cannot separate peptides of similar size
• Limited loading capacity
• Not suitable for crude mixture separation

Multimodal and mixed-mode chromatography

Multimodal chromatography uses a single resin that combines two separation mechanisms. The most common for peptides:

HIC-cation exchange (HIC-IEX):

• Binds peptides at high salt (HIC mechanism)
• Elutes at low salt with pH gradient (IEX mechanism)
• Particularly useful for complex crude mixtures
• Salt-tolerant — can follow IEX capture without desalination

Mixed-mode anion/cation exchange:

• Resin has both positive and negative charge sites
• Separates charge variants and hydrophobic variants simultaneously
• Used for GLP-1 peptides with complex impurity profiles

Practical purification strategy for GLP-1 peptides

A typical GLP-1 peptide purification workflow:

• **Capture** (optional): IEX or multimodal chromatography to remove the bulk of impurities and salts
• **Primary purification**: RP-HPLC at low pH (0.1% TFA) to separate the target from truncation and deletion sequences
• **Secondary purification** (optional): RP-HPLC at high pH (NH4HCO3) to resolve any impurities that co-eluted at low pH
• **Polishing**: SEC or diafiltration for buffer exchange and aggregate removal
• **Quality control**: HPLC purity, MS identity, endotoxin, residual solvents

For GLP-1 analogs like tirzepatide and semaglutide, the fatty acid conjugation step may require orthogonal purification (HIC) to remove incorrectly conjugated material before or after the main RP-HPLC step.

Reading the COA: what the purification method tells you

| Purification method | What it removes well | What it may miss | | --- | --- | --- | | RP-HPLC only | Hydrophobic impurities, truncation sequences | Charge variants (deamidation, oxidation) | | RP-HPLC + IEX | Hydrophobic impurities + charge variants | Aggregates (if SEC not used) | | RP-HPLC + HIC | Hydrophobic impurities + aggregate variants | Very polar impurities | | Full multimodal workflow | All major impurity classes | Minimal residual impurities |

If your application requires absolute purity from charge variants (e.g., receptor binding studies), request that the COA include both RP-HPLC purity and charge variant analysis (iCIEF or capillary electrophoresis).

ZePeptide uses RP-HPLC as the primary purification method for all GLP-1 peptides, with HIC as a secondary step for fatty acid-conjugated compounds and SEC for aggregate monitoring. Full analytical characterization is available on request.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.